Progyny operates as a benefits management company specializing in fertility, family building, and women's health solutions for employers and their employees in the United States. The company provides differentiated fertility benefits plan design, including its smart cycle treatment bundle, alongside personalized concierge-style member support services and access to a selective network of fertility specialists. Progyny also operates Progyny Rx, an integrated pharmacy benefits solution that supplies medications required during treatment and offers associated care management services.
The company's service offerings extend beyond core fertility treatment to include an assistance service program covering adoption reimbursement, surrogacy support, doula services, and travel reimbursement for cases where travel is necessary to access medical care. This diversified approach to family building benefits differentiates its positioning within the health benefits space.
Progyny operates with a workforce of approximately 675 full-time employees and maintains headquarters in New York, New York. The company was incorporated in 2008 as Auxogyn, Inc. before adopting its current name in 2015 and is listed on the Nasdaq exchange.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $0.14 | $0.15 | +16.7% | |
| 2024 | $0.12 | $0.12 | -7.7% | |
| 2023 | $0.13 | $0.14 | +333.3% | |
| 2022 | $0.03 | $0.04 | -80.0% | |
| 2021 | $0.15 | $0.17 | -61.5% | |
| 2020 | $0.39 | $0.45 | +195.1% | |
| 2019 | $-0.41 | $-0.41 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-27 | 0001551306-26-000020 | SEC ↗ |
| 2024-12-31 | 2025-03-03 | 0001551306-25-000040 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0001551306-24-000031 | SEC ↗ |
| 2022-12-31 | 2023-03-01 | 0001551306-23-000015 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0001558370-22-002466 | SEC ↗ |
| 2020-12-31 | 2021-03-01 | 0001558370-21-002082 | SEC ↗ |
| 2019-12-31 | 2020-03-10 | 0001558370-20-002258 | SEC ↗ |